• Facebook
  • Twitter
  • Youtube
  • Instagram
  • LinkedIn
  • Rss
  • Store
  • Donate
NCCS - National Coalition for Cancer Survivorship
  • About
        • About Us

        • NCCS is the oldest cancer survivor-led non-profit organization in America. We advocate for quality cancer care for all touched by cancer.

        • About NCCS

        • Our Mission
        • What is Advocacy?Learn about the different types of cancer advocacy, from personal advocacy to public interest advocacy.
        • Our HistoryRead how NCCS’s leaders coined the term “cancer survivor,” and established the nation’s first survivor-led non-profit organization.
        • Our Team
        • Financial Information
        • Employment
        • Contact Us
        • Support Our Mission

        • Make A GiftSupport our mission of quality cancer care for all with a gift to NCCS.
        • The 1986 ClubMake a monthly commitment to support NCCS, empower cancer survivors, and advance public policy.
        • Ways to GiveLearn about other ways you can contribute to NCCS such as planned giving, employer matches, shopping online, and more.
        • Partnerships
  • News
    • NCCS News
    • Advocate SpotlightEach month, NCCS highlights a cancer survivorship advocate, sharing their story and the work they do in their communities.
    • Policy CommentsRead NCCS’s comments to Congress, HHS, and other federal policymakers in Washington, DC on proposed rules and legislation.
    • Issue StatementsRead NCCS statements on pressing issues and developments in Washington affecting cancer survivors and their families.
  • Policy
        • Policy

        • Public policy is government action, in the form of legislation, regulation, funding, and other actions. Public policy affects people with cancer and the cancer care system in many ways.

        • Our Policy Priorities

        • Quality Cancer CareQuality cancer care is essential for patients. Learn how NCCS and others define quality.
        • Access to CareNCCS believes cancer care and clinical trials should be affordable and accessible to everyone.
        • Health EquityThe cancer experience is not the same for everyone. NCCS works on policy efforts to reduce disparities in outcomes.
        • Current Issues

        • Comprehensive Cancer Survivorship Act (CCSA)The CCSA is a large comprehensive bill introduced in Congress that aims to improve quality of care in all stages of a diagnosis.
        • Cancer Care Planning and Communications Act (CCPCA)CCPCA is a bill that would provide a billable Medicare service code for cancer care planning.
        • DIEP Flap AccessNCCS advocates for protection of access to DIEP Flap Breast Reconstruction Surgery for all breast cancer survivors.
        • Policy CommentsRead NCCS’s comments to Congress, HHS, and other federal policymakers in Washington, DC on proposed rules and legislation.
        • Issue StatementsRead NCCS statements on pressing issues and developments in Washington affecting cancer survivors and their families.
        • Quality Measurement Research
  • Get Involved
        • Get Involved

        • Whether you’re new to cancer advocacy or already have experience as an advocate, there are numerous ways you can get involved with NCCS.

        • Join NCCS

        • Cancer Policy and Advocacy Team (CPAT)CPAT is a program for survivors and caregivers to learn about pressing issues that affect quality cancer care, in order to be engaged as advocates in public policy.
        • Elevating SurvivorshipA patient-led initiative — NCCS mentors advocates (Elevate Ambassadors) to fill vital gaps in survivorship care in their community.
        • Survivorship ChampionsAn NCCS program for clinicians and researchers who are interested in improving care for cancer survivors.
        • Advocacy OpportunitiesThis page provides a list of upcoming events, webinars, conferences, and advocacy campaigns from NCCS and other leading cancer organizations.
        • Connect with Us

        • Subscribe to NCCS Updates
        • Follow NCCS on Social Media
        • Survivor Stories
        • Cancerversary
        • Support NCCS

        • Make A Gift
        • Ways to Give
        • The 1986 Club
  • Survivorship Survey
        • State of Cancer Survivorship

        • NCCS conducts an annual State of Survivorship Survey, in partnership with Edge Research, to delve into the cancer patient and survivor journey. This study captures a range of perspectives to better understand how NCCS can support its mission to advocate for quality cancer care for all.

        • Reports by Year

        • 2023 Survey ReportThe 2023 Survey explored the caregiver experience for the first time, and features new data on the effect of cancer treatment on employment.
        • 2022 Survey ReportThe 2022 Survey found significant disparities in cancer care that impact people of color, young adults, women, and those with metastatic cancer, at higher rates.
        • 2021 Survey ReportThe 2021 Survey demonstrated that when patients receive quality care, have excellent support, and have financial resources, they are more likely to have positive outcomes.
        • 2020 Survey ReportIn the 2020 Survey, survivors reported that their care team is not helpful at addressing some common side effects of their cancer such as fatigue, anxiety, and depression.
  • Survivorship Checklist
        • Cancer Survivorship Checklist

        • The Cancer Survivorship Checklist is designed to be a simple, straightforward tool patients and caregivers can use as a guide for information critical to their care wherever they are on the cancer care continuum.

        • Start Your Cancer Survivorship Checklist
        • Survivorship Checklist Guide for Clinicians
        • Resources for Cancer Survivors

        • Survivorship ResourcesA collection of resources that provide information about navigating the cancer journey.
        • Cancer RehabilitationA supportive health care service that helps improve a person’s functioning during and after cancer treatment.
        • Integrative OncologyA field that combines traditional cancer treatments with therapies that support a person’s natural healing ability.
  • Resources
        • Resources

        • NCCS provides a wide variety of resources for both patients and caregivers.

        • Resources for Survivors and Caregivers

        • Cancer Survival ToolboxA free, award-winning audio program created by leading cancer organizations to help people better meet & understand the challenges of their illness.
        • Telehealth
        • Care Planning for Cancer Survivors
        • Remaining Hopeful
        • Self Advocacy
        • Talking With Your Doctor
        • Taking Charge of Your Care
        • Order Our Resources
        • Resources for Health Care Professionals

        • Tools For Care Providers
        • Telehealth Project
        • Survivorship Champions Webinars
        • Survivorship Checklist Guide for Clinicians
  • Events
    • Ellen L. Stovall Award
      • 2023 Winners
      • Awardees
      • Reception and Sponsorship
      • Committees
      • Nominations
    • Cancer Policy Roundtable (CPR)
      • Spring 2023 CPR
      • Fall 2022 CPR
      • Spring 2022 CPR
    • 2023 Survivorship Survey
    • Webinars
  • 0

Your generous year-end donation will be matched $1 for $1    DONATE

FacebookProfile3

NCCS and CLC Comments on PCORI research priorities

March 15, 2012/in Cancer News, Policy Comments Quality Cancer Care, Survivorship Care NCCS News, Policy Comments

Joe Selby, M.D., M.P.H
Executive Director
Patient-Centered Outcomes Research Institute

Re: Draft National Priorities for Research and Research Agenda

Dear Dr. Selby:

The undersigned organizations, representing cancer patients, physicians, and researchers, are pleased to provide comments on the Patient-Centered Outcomes Research Institute (PCORI) Draft National Priorities for Research and Research Agenda (version 1). We commend PCORI for developing five broad priorities for patient-centered comparative clinical effectiveness research. We offer advice to PCORI and the research community regarding promising research initiatives that are consistent with these research priorities and that would, consistent with the PCORI mission, “offer patients and caregivers the information they need to make important healthcare decisions.”

Assessment of Prevention, Diagnosis, and Treatment Options

The PCORI Proposed Research Agenda identifies as a priority area research that is related to the assessment of prevention, diagnosis, and treatment options. The agenda states that the research should focus on “biological, clinical, economic, and geographic factors that may affect patient outcomes.” We recommend as a special area of emphasis research projects that would evaluate strategies to ensure the best possible patient outcomes from use of targeted cancer therapies.

Important advances in the understanding of cancer have contributed to the development of targeted cancer therapies that block the growth and spread of cancer by interfering with specific molecules involved in tumor growth and disease progression. These treatments may offer significant benefits to cancer patients, sometimes without the side effects of chemotherapy or radiation therapy.

However, the appropriate use of such targeted therapies may depend on timely and accurate diagnostic testing of individuals to ensure that they will benefit from the treatment. There are economic, medical practice, and educational and communication barriers to the proper utilization of diagnostic tests that inform the use of targeted therapies, and evaluation of these obstacles and identification of strategies for addressing them might be the focus of research supported by PCORI.

Improving Healthcare Systems

Research on management of the late and long-term effects of cancer and cancer treatment

Consistent with the PCORI research agenda that focuses on ways to improve access to care, receipt of care, coordination of care, self-care, and decision-making, we recommend research on management of late and long-term effects experienced by cancer survivors. Cancer survivors may experience a wide range of side effects of cancer and cancer treatment, varying in their impact on quality of life and in their severity. Although the side effects experienced by adult cancer survivors will vary by cancer diagnosis and treatment received, these effects might include cardiovascular disease, fatigue, cognitive impairment, psychological distress, infertility, and lymphedema. Cancer survivors may also be at risk of a cancer recurrence or second primary cancer. The side effects experienced by childhood cancer survivors are also significant. The Institute of Medicine (IOM) found that, “As many as two-thirds of childhood cancer survivors are likely to experience at least one late effect, with perhaps one-fourth of survivors experiencing a late effect that is severe or life threatening.” Among the late effects experienced by childhood cancer survivors are neurocognitive and psychological, cardiopulmonary, endocrine, musculoskeletal, and second malignancies.

Cancer survivors—whether diagnosed as children, adolescents, or adults –face serious challenges associated with the management of the late and long-term effects of their cancer and treatment for cancer. We recommend a number of research initiatives that would investigate optimal strategies for managing the co-morbidities experienced by cancer survivors. These projects might be focused on:

Evaluating the impact of written treatment summaries and survivorship plans on the receipt of appropriate care for management of effects of cancer and care treatment; the coordination of all elements of health care monitoring and side effects management; self-care by survivors; and decision-making about nature and scope of survivorship care.
Assessing the optimal site of care for survivors of childhood cancer and the transition from pediatric to adult systems of care and the impact of such transitions on childhood cancer survivors and their health outcomes.
Research to determine the best health care teams for management of complex care

Cancer care is typically multi-disciplinary and often long-term. The challenges associated with cancer care delivery are becoming even greater, with the development of oral, self-administered therapies that raise adherence issues and targeted therapies that require access to diagnostics to guarantee appropriate use of the therapy. In addition, cancer patients may encounter difficulties in understanding their financial responsibilities for care. Further complicating the cancer care situation is the projected deep shortage of oncologists.

Patient navigators have in some settings played a role in assisting cancer patients in management of their care. Questions still arise regarding the appropriate training for navigators and the scope of their engagement in the system of care. In addition, other sorts of cancer care teams – perhaps utilizing navigators but relying on other health professionals in addition to physicians –are being utilized in a range of health care systems. We recommend research initiatives that would evaluate the impact of cancer care teams of different composition (including navigators and health professionals collaborating with physicians) on care delivery, quality of care, and patient satisfaction with care.

Research related to provider acceptance of new technology, treatments, and practice standards

Cancer care in the United States has always evolved rapidly, with researchers providing information about new uses of approved therapies, innovators bringing new products to the market, and surgeons introducing enhancements into practice. In recent years, cancer patients have become aggressive consumers of information, monitoring research developments carefully to integrate them into their care. The process for incorporating new treatments into the standard of care has been strained by the pace of discovery and the consumer command of information about possible new treatments.

We identify two recent developments in cancer care to illustrate the challenges facing cancer care providers in incorporating new standards of care into their practice. New therapies that are targeted to individuals with a specific molecular profile require use of a diagnostic test to determine those who will benefit from a particular therapy, a testing process that may in some circumstances present substantial burdens. The American Society of Clinical Oncology (ASCO) recently released a Provisional Clinical Opinion recommending the incorporation of palliative care into oncology care, a change in practice that will require adaptation and adjustment.

We recommend research into effective means of disseminating information about new practice standards to health care professionals and dissemination of the same information to patients. This research will support changes in the health care delivery system for better coordination of care and also access to best available care.

Communication and Dissemination

We applaud PCORI for the substantial emphasis on improved communication to facilitate patient engagement and decision-making. There is strong support among cancer patient advocates, physicians, and caregivers for the development of a written cancer care plan outlining all elements of active treatment and symptom management and coordinating all aspects of cancer care, to be provided to the individual patient by his or her care team. Such written care plan—to be updated when there is a significant modification in treatment, a change in the individual’s condition, or a transition to long-term survivorship –is considered an aid to patient decision-making and involvement in the care process and a means to facilitate the coordination of care provided by multiple physicians and care teams.

We recommend research on several elements of the cancer care planning process, to ensure that there is broad provider acceptance of this practice and guarantee that the plans that are communicated to patients are adequate to support informed decision-making.

We urge:

Research to determine the most effective professional education strategies for encouraging the adoption of cancer care planning as an essential element of cancer care delivery.
Evaluation of the elements that are critical for inclusion in the written care plan, to ensure that the document is adequate to support decision-making but also consumer-friendly.
Investigation of solutions to potential challenges related to development and delivery of cancer care plans to underserved populations, including minority populations.
Research on these issues will strengthen the quality of cancer care plans, facilitate their incorporation in practice, and empower patients for participation in their care.

Addressing Disparities

We commend the decision to include disparities as part of the research agenda and are pleased that PCORI will consider disparities related to race/ethnicity and other causes of disparities in disease incidence and survival, including socioeconomic status, gender, and geographic location. Research has shown that these different disparities influence the time of cancer diagnosis as well as outcomes. For example, African Americans are more likely to be diagnosed with and die from cancer than any other racial or ethnic group. In addition, as reported by the American Cancer Society, “Persons with lower socioeconomic status (SES) have disproportionately higher cancer death rates than those with higher SES, regardless of demographic factors such as race/ethnicity.” Research in this area holds the promise of reducing disparities, including the disparities seen in diagnosing cancer at an early stage, when odds for survival are typically higher.

Accelerating Patient-Centered and Methodological Research

We are pleased that the PCORI agenda includes research on the use of registries and clinical data networks to support research about patient-centered outcomes. We believe there is promise in the use of registries and databases to document patterns of care and the effectiveness of health care interventions over time. To achieve that end, it is appropriate for PCORI to invest in research to 1) improve the quality of clinical data in registries and databases, 2) identify options for design of effective and efficient databases and registries, and 3) develop strategies for enhanced health professional and patient utilization of registries.

We appreciate the opportunity to comment on the first version of the PCORI research agenda and look forward to additional occasions to offer our input into the PCORI research program. Our research recommendations are specific to cancer patients and providers, as that is our area of expertise and experience. However, our proposals are generally appropriate as recommendations for research on chronic disease management more generally. We also realize that the demands on the PCORI budget are great, as the research program must address a wide range of research topics and priorities.

Sincerely,

Cancer Leadership Council

American Society for Radiation Oncology
American Society of Clinical Oncology
Bladder Cancer Advocacy Network
Cancer Support Community
The Children’s Cause for Cancer Advocacy
Coalition of Cancer Cooperative Groups
College of American Pathologists
International Myeloma Foundation
The Leukemia & Lymphoma Society
LIVESTRONG
Lymphoma Research Foundation
Multiple Myeloma Research Foundation
National Coalition for Cancer Survivorship
National Lung Cancer Partnership
Ovarian Cancer National Alliance
Prevent Cancer Foundation
Sarcoma Foundation of America
Susan G. Komen for the Cure Advocacy Alliance
Us TOO International Prostate Cancer Education and Support Network

Tags: patient first, policy comments
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on LinkedIn
https://canceradvocacy.org/wp-content/uploads/2014/06/FacebookProfile3.png 280 280 actualize https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png actualize2012-03-15 09:44:302012-03-15 09:44:30NCCS and CLC Comments on PCORI research priorities

Latest News

Webinar – Reconnecting to Life After Cancer: Permission to Feel

December 7, 2023
The National Coalition for Cancer Survivorship (NCCS) presents "Reconnecting to Life After Cancer: Permission to Feel," a webinar featuring…
Read more
https://canceradvocacy.org/wp-content/uploads/Kathy-Washburn-CPAT-Webinar-Cancer-Coach-post.jpg 600 1200 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2023-12-07 18:00:382023-12-07 18:00:38Webinar – Reconnecting to Life After Cancer: Permission to Feel
NCCS Advocate Spotlight: Tamron Little

The Advocate Within: Tamron Little’s Remarkable Journey of Turning Trauma into Triumph

December 6, 2023
Advocate Spotlight: Tamron Little Tamron Little was a 21-year-old college student and pregnant with her first child when she was…
Read more
https://canceradvocacy.org/wp-content/uploads/Tamron-Little-Advocate-Spotlight-Blog-Banner.jpg 600 1200 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2023-12-06 10:24:262023-12-06 10:24:26The Advocate Within: Tamron Little’s Remarkable Journey of Turning Trauma into Triumph
Advocate Spotlight: Mary Glen, with photo of Mary.

The Not-So-Good Cancer: Mary Glen’s Inspiring Advocacy Journey

November 8, 2023
Advocate Spotlight: Mary Glen Mary Glen was serving as an active-duty Army officer, deployed to South Korea in August 2020. Just…
Read more
https://canceradvocacy.org/wp-content/uploads/Mary-Glen-Advocate-Spotlight-Blog-Banner.jpg 600 1200 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2023-11-08 11:55:412023-11-08 11:55:41The Not-So-Good Cancer: Mary Glen’s Inspiring Advocacy Journey

Take Action

Link to: Survivorship Champions

Become a Survivorship Champion

Survivorship Champions is a program for all clinicians and researchers, both oncology and primary care, who are interested in improving survivorship care and primary care’s role in caring for cancer survivors.

Learn More and Join »
Link to: Cancer Policy and Advocacy Team (CPAT)

Join CPAT

The NCCS Cancer Policy & Advocacy Team (CPAT) is a program for survivors and caregivers to learn about pressing policy issues that affect quality cancer care in order to be engaged as advocates in public policy around the needs of cancer survivors.

Learn More and Join »
Link to: Survivor Stories

Share Your Story

NCCS represents the millions of Americans who share a common experience – living with, through and beyond a cancer diagnosis. By sharing your story of how you have been touched by cancer, you are supporting the national cancer survivorship movement.

Share Your Story »

STAY CONNECTED

Together we can improve cancer care for survivors! Sign up to be the first to know about cancer policy issues and ways to take action

  • This field is for validation purposes and should be left unchanged.

  • About
    • Our Mission
    • What is Advocacy?
    • Our History
    • Our Team
    • Financial Information
    • Employment
    • Contact Us
    • Make A Gift
    • The 1986 Club
    • Ways to Give
    • Partnerships
  • News
    • NCCS News
    • Advocate Spotlight
    • Policy Comments
    • Issue Statements
  • Policy
    • Quality Cancer Care
    • Access to Care
    • Health Equity
    • Comprehensive Cancer Survivorship Act (CCSA)
    • Cancer Care Planning and Communications Act (CCPCA)
    • DIEP Flap Access
    • Policy Comments
    • Issue Statements
    • Quality Measurement Research
  • Get Involved
    • Cancer Policy and Advocacy Team (CPAT)
    • Survivorship Champions
    • Elevating Survivorship
    • Advocacy Opportunities
    • Subscribe to NCCS Updates
    • Follow NCCS on Social Media
    • Survivor Stories
    • Cancerversary
    • Make A Gift
    • The 1986 Club
    • Ways to Give
  • Survivorship Survey
    • 2023 Survey Report
    • 2022 Survey Report
    • 2021 Survey Report
    • 2020 Survey Report
  • Survivorship Checklist
    • Start Your Cancer Survivorship Checklist
    • Survivorship Resources
    • Cancer Rehabilitation
    • Integrative Oncology
    • Survivorship Checklist Guide for Clinicians
  • Resources
    • Cancer Survival Toolbox
    • Telehealth
    • Care Planning for Cancer Survivors
    • Remaining Hopeful
    • Self Advocacy
    • Talking With Your Doctor
    • Taking Charge of Your Care
    • Order Our Resources
    • Tools For Care Providers
    • Telehealth Project
    • Survivorship Champions Webinars
    • Survivorship Checklist Guide for Clinicians
  • Events
    • Ellen L. Stovall Award
      • 2023 Winners
      • Awardees
      • Reception and Sponsorship
      • Committees
      • Nominations
    • Cancer Policy Roundtable (CPR)
      • Spring 2023 CPR
      • Fall 2022 CPR
      • Spring 2022 CPR
    • 2023 Survivorship Survey
    • Webinars
  • Search
  • Cart

National Coalition for Cancer Survivorship
8455 Colesville Road  |  Suite 930  |  Silver Spring, MD 20910
877-NCCS-YES  |  info@canceradvocacy.org
Privacy Policy  |  Terms and Conditions

Copyright © 1995-2023 by the National Coalition for Cancer Survivorship
National Coalition for Cancer Survivorship, NCCS, Cancer Survival Toolbox, and related Logos are registered in the United States as trademarks of the National Coalition for Cancer Survivorship.

Beating the oddsPlans for Improving Cancer Survivorship CareFacebookProfile3CBO report says healthcare law could cause as many as 20M to lose coverage
Scroll to top
Download the Survey Report

"*" indicates required fields

Fill out the form below, and we’ll send the survey report, detailed presentation, and infographic to your email.
Name*
I am a...*
Select any/all that apply.
Consent*
By downloading the survey materials, you will receive updates and information from NCCS via email, which you may unsubscribe from at any time. Your information will never be sold to any third parties.
This field is for validation purposes and should be left unchanged.

Download the Survey Report

"*" indicates required fields

Fill out the form below, and we’ll send the survey report, detailed presentation, and infographic to your email.
Name*
I am a...*
Select any/all that apply.
Consent*
By downloading the survey materials, you will receive updates and information from NCCS via email, which you may unsubscribe from at any time. Your information will never be sold to any third parties.
This field is for validation purposes and should be left unchanged.

Get Updates From NCCS

Be the first to hear about cancer policy and survivorship issues! Subscribe and receive the biweekly NCCS Health Care Roundup, invites to webinars and events, and more.

  • This field is for validation purposes and should be left unchanged.

Connect With Us

Twitter     Facebook     Instagram     LinkedIn     YouTube

Harmar Brereton, MD

Founder
Northeast Regional Cancer Institute

 

“Perhaps one of the most impactful collaborations in Dr. Brereton’s extraordinary career remains his early work and long friendship with Ellen Stovall. Through him, and in turn through the thousands of lives he has touched, Ellen’s work continues, and her mission lives on.”

—Karen M. Saunders
President, Northeast Regional Cancer Institute